Climb Bio, Inc.
Climb Bio, Inc. (CLYM) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
clym · stock forecast · 5 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 5 Wall Street analysts in the past 3 months
Buy
5 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$35.00
Consensus
$21.88
+103.2% upside
Low
$17.00
Median: $20.5 · Last Close: $10.77
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$21.88
103.2% upside
High Target
$35
225.0%
Low Target
$17
57.8%
Current Price
$10.77
as of today
Based on analyst price targets, the CLYM stock price prediction for the next 12 months ranges from $17 to $35. The consensus CLYM price forecast of $21.88 implies 103.2% upside from the current price of $10.77.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $10.60 | ↓ 1.59% |
1-day model range: $10.49–$10.71. Peak: $10.71 (-1.59%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $8 | -28.1% |
| 2028 | $7 | -39.2% |
| 2029 | $6 | -44.3% |
| 2030 | $6 | -46.9% |
| 2031 | — | -48.3% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CLYM · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-08 | Wedbush | Maintains | Outperform→Outperform |
| 2026-05-06 | BTIG | Maintains | Buy→Buy |
| 2026-04-21 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-04-08 | BTIG | Maintains | Buy→Buy |
| 2026-03-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-06 | Baird | Maintains | Outperform→Outperform |
| 2026-03-06 | Wedbush | Maintains | Outperform→Outperform |
| 2025-12-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-16 | BTIG | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Climb Bio, Inc. (CLYM) stock. Of the recent 12 rating actions, 0 were upgrades and 0 were downgrades. 5 analysts currently cover CLYM.
Analyst Recommendation Trends
CLYM analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 3 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
Revenue Next Year
$1M
EPS This Year
$-0.88
EPS Next Year
$-1.06
↑ 20.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast CLYM EPS of $-0.88 for the current fiscal year, based on estimates from 10 analysts. The CLYM revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CLYM stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CLYM price target is $21.88 (+103.2% upside), with an analyst consensus of Buy.
The CLYM short-term stock prediction for tomorrow is $10.60 (-1.59%). The CLYM stock price prediction for 2027 estimates an average of $8. The CLYM stock prediction for 2030 projects a range of $5–$6.
Climb Bio, Inc. trades on NASDAQ under the ticker CLYM. The CLYM stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
CLYM forecast · 8 questionsAccording to 5 Wall Street analysts, the average 12-month CLYM price target is $21.88, with a high forecast of $35.00 and a low of $17.00. The median price target is shown in the chart above when available. This implies +103.2% potential upside from the current price of $10.77.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.